The largest database of trusted experimental protocols

Spss 13.0 software for windows

Manufactured by IBM
Sourced in United States

SPSS 13.0 is a statistical software package designed for Windows operating systems. It provides tools for data analysis, data management, and data presentation. The software is capable of handling a variety of data types and offers a range of statistical techniques, including regression analysis, hypothesis testing, and cluster analysis.

Automatically generated - may contain errors

58 protocols using spss 13.0 software for windows

1

Statistical Analysis of Experimental Data

Check if the same lab product or an alternative is used in the 5 most similar protocols
Data are presented as the means ± SDs. The statistical significance of differences was analyzed by Student's t-test and Wilcoxon rank test using SPSS software 13.0 for Windows (SPSS, USA). A p value less than 0.05 was considered significant.
+ Open protocol
+ Expand
2

Statistical Analysis of Disease Prognosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Statistical analysis was performed with SPSS software 13.0 for Windows (SPSS Inc., USA). Excel and GraphPad Prism version 6 (GraphPad Software, San Diego, CA, USA) were employed to process initial data and for graph plotting. Student’s t test was performed to assess the statistical significance of differences. Survival analysis was conducted using the Kaplan–Meier method and log-rank test. The Cox proportional hazards model was used for univariate and multivariate analyses of disease prognosis. P< 0.05 is considered statistically significant. * indicates P< 0.05 and ** indicates P< 0.01. All values are expressed as the means ± standard deviation.
+ Open protocol
+ Expand
3

Antioxidant Potential Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Each experiment was performed in triplicate and the data were recorded as mean ± SD (standard deviation). The dose–response curves were plotted using Origin 6.0 professional software (OriginLab, Northampton, MA, USA). The IC50 value was defined as the final concentration of 50% radical inhibition (or relative reducing power) [50 (link)]. It was calculated by linear regression analysis, and expressed as the mean ± SD (n = 3). The linear regression was analyzed using Origin 6.0. Determination of significant differences between the mean IC50 values was performed using one-way ANOVA and the t-test. The analysis was performed using SPSS software 13.0 for Windows (SPSS Inc., Chicago, IL, USA). p < 0.05 was considered to be statistically significant.
+ Open protocol
+ Expand
4

Triplicate Experimental Data Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples were run in triplicate and the data were presented as the mean ± standard deviation. Statistically significant differences were analyzed via one-way analysis of variance followed by and SNK test using SPSS software 13.0 for Windows (SPSS, Inc.). P<0.05 was considered to indicate a statistically significant difference.
+ Open protocol
+ Expand
5

Relative Expression Analysis of PCR Data

Check if the same lab product or an alternative is used in the 5 most similar protocols
The relative expression software tool was used to evaluate the quantitative statistical value of PCR group-wise comparisons based on PCR efficiency and the mean crossing point deviation between the sample and control group. The above experimental procedures were repeated and analyzed three times. Statistical significance was analyzed by performing a one-way analysis of variance (ANOVA) or the Student t test with SPSS software 13.0 for Windows (SPSS Inc., Chicago, IL). A p-value<0.05 was considered statistically significant.
+ Open protocol
+ Expand
6

Statistical Analysis of Research Data

Check if the same lab product or an alternative is used in the 5 most similar protocols
Statistical analysis was performed using SPSS 13.0 software for Windows. Differences in characteristics or values were examined by χ2 and Fisher's exact tests. Statistical significance was based on a P-value of < 0.05.
+ Open protocol
+ Expand
7

Cognitive Decline Mitigating Interventions

Check if the same lab product or an alternative is used in the 5 most similar protocols
All data are presented as means ± standard deviations (SDs). Group variance was determined with one-way analyses of variance (ANOVAs) followed by Fisher's least significant difference (LSD) multiple comparison post hoc tests in SPSS 13.0 software for Windows (version 13.0; SPSS, Chicago, Illinois), except for Morris water maze escape latency data, which were analyzed with a two-way repeated measures ANOVA. Probability values < 0.05 were considered statistically significant.
+ Open protocol
+ Expand
8

Univariate Analysis of Experimental Data

Check if the same lab product or an alternative is used in the 5 most similar protocols
The SPSS 13.0 software for Windows was used for all statistical analyses in this study. Univariate analysis was used to analyze the main effect and interactive effect. All results were represented in terms of mean ± SEM, and P < 0.05 was implied a significant difference.
+ Open protocol
+ Expand
9

Metabolic Syndrome and Gallstone Disease

Check if the same lab product or an alternative is used in the 5 most similar protocols
Statistical analyses were performed using SPSS 13.0 software for Windows (SPSS Inc., Chicago, IL). Continuous variables were expressed as mean and standard deviation or median and interquartile range (25%–75%), according to the normality of the data. Comparisons between the independent groups were conducted using Student’s t-test or the Mann-Whitney U test. Categorical variables were compared using the chi-square test. Univariate and multivariate logistic regression analyses were conducted to assess the odds ratio (OR) for metabolic syndrome, comparing subjects with gallstone disease to those without gallstone disease. P<0.05 (2-tailed) was considered statistically significant.
+ Open protocol
+ Expand
10

Synergistic Anticancer Drug Combination Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Statistical analyses were performed with SPSS 13.0 software for Windows (SPSS Inc., Chicago, IL, USA). Excel and GraphPad Prism version 6 (GraphPad Software, San Diego, CA, USA) were employed to process the initial data and plot the results. The CI was calculated with CompuSyn software to analyse the synergistic inhibitory effect of the drug combinations. Student’s t-test and one-way analysis of variance were performed to assess the statistical significance of differences. P<0.05 was considered statistically significant. * P<0.05 and ** P<0.01. All values are expressed as means±s.d.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!